Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1626 1691
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18527530 | FERMENTATIVELY-PRODUCED RETINOID CONTAINING COMPOSITIONS, AND THE METHDOS OF MAKING AND USING THE SAME | Non-Final OA | DSM IP Assets B.V. |
| 18630042 | ACCESSING AND MODULATING THE COLOR AND VIBRANCY OF ANODICALLY COLORING ELECTROCHROMIC MOLECULES | Non-Final OA | Georgia Tech Research Corporation |
| 18003431 | HISTONE-ACETYLATION-MODULATING AGENTS FOR THE TREATMENT AND PREVENTION OF ORGAN INJURY | Final Rejection | The Regents of the University of Michigan |
| 18245941 | PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT COMPOUND CONJUGATED TO G4 STRUCTURES OF CORONAVIRUSES FOR PREVENTION OR TREATMENT OF CORONAVIRUS INFECTIOUS DISEASES | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18471375 | PHTHALAZINE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 | Non-Final OA | Merck Sharp & Dohme LLC |
| 17588104 | REDUCTION OF ER-MAM-LOCALIZED APP-C99 AND METHODS OF TREATING ALZHEIMER'S DISEASE | Final Rejection | The Trustees of Columbia University in the City of New York |
| 18530612 | METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY | Final Rejection | Massachusetts Institute of Technology |
| 18720716 | COMPOSITIONS COMPRISING UROLITHIN FOR TREATING MUSCLE DECLINE AND A KIDNEY DYSFUNCTION | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18144230 | PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY COMPRISING MELATONIN AND PROSTAGLANDIN E2 FOR TREATING INTESTINAL EPITHELIAL INJURY AS AN ACTIVE INGREDIENT | Final Rejection | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION |
| 18109406 | COMPOSITIONS AND METHODS OF REDUCING SERUM CHOLESTEROL AND PCSK9 | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18706095 | USE OF APOMORPHINE AS THERAPEUTIC AGENT FOR NECROPTOSIS-RELATED DISEASES | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18167110 | AMINO ACID COMPOSITIONS AND USES THEREOF | Final Rejection | AMILYFE, LLC |
| 18288692 | PCNA INHIBITORS AND EGFR INHIBITORS FOR CANCER TREATMENT | Non-Final OA | City of Hope |
| 17904393 | AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2 | Non-Final OA | UCL BUSINESS PLC |
| 18697655 | PHARMACEUTICAL COMBINATION CONTAINING CAPSID PROTEIN INHIBITOR AND REVERSE TRANSCRIPTASE INHIBITOR | Non-Final OA | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy